| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8951074 | The Annals of Thoracic Surgery | 2018 | 8 Pages |
Abstract
PORT is not independently associated with decreased LR or improved DFS/LCSD in this patient population. Given that the predominant failure pattern was distant recurrence, future clinical trials should focus on adjuvant systemic therapies, which may decrease distant recurrences in ypN2 patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Whitney S. MD, Wanpu MD, Jonathan E. MD, Kay See PhD, Bernard J. MD, Prasad S. MD, Matthew J. MD, Daniela MD, James MD, Jamie MD, Andreas MD, David R. MD,